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Abstract
Identification, characterization, and purification of allergens are essential for the structural and
immunologic studies needed to understand how these molecules induce specific IgE antibody
production by the human immune system. Advances in molecular biology techniques have led to
the production of recombinant allergens having constant properties, allowing detection of specific
IgE directed against different molecular components of an allergenic source. Presence of
homologous allergens in different sources is the reason for cross-reaction. Molecule-based
diagnostic tools can lead to better interpretation of poly-sensitizations, observed by ST and in vitro
tests using allergenic extracts as they were made before. Some examples IgE sensitization to major
genuine allergens and panallergens will be presented.
The Pharaoh's death tale occurred in ancient Egypt van-
ishes into thin air. It could have been due to anaphylactic
shock caused by a bee's sting. Before and after that time
and throughout millennia similar events, which hap-
pened to other human beings, have not been explained.
The era of the diagnosis in allergy began during the last
part of the nineteenth century when the skin test (ST) with
very raw extracts from presumed allergenic sources were
first applied to humans [1]. In 1967 after the discovery of
specific IgE in the sera of myeloma patients [2], in vitro
tests for allergy diagnosis started to appear on the scene
[3]. To date these tests as well the ST are based on aller-
genic extracts, the same used for specific immunotherapy.
The real "Copernican revolution" in the allergy field
started during the late eighties, when the first recom-
binant allergen was cloned; since then allergology and
molecular biology joined together, beginning a closer and
essential relationship [4].
As far as there is still some confusion on the proper use of
some terms, an appropriate terminology is needed in
order to follow this review: "allergenic source", "allergenic
extract", "allergen" are not interchangeable terms [4].
Allergenic Source
This term is used to identify the allergenic source material
often matching a whole organism (i.e. mite and moulds)
sometimes describing some of its tissues (i.e. the dog epi-
thelium, the hen's egg, the cow's milk). In both cases they
are allergenic sources, not allergens as they are often
defined.
Allergenic extract
The allergenic extracts normally used in vivo diagnosis
(i.e. ST) and in vitro diagnosis (e.g. RAST, ImmunoCAP,
Immulite) come from defined allergenic sources as exem-
plified above. They are obtained by several different buffer
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extraction procedures, in general optimized to extract
most of the unknown proteins from the raw material.
Allergens and allergenic epitopes
Allergens are proteins or glycoproteins having a molecular
weight ranging from 5 to 150 kDa, and an isoelectric
point between 4 and 9. Allergenic determinants or
epitopes represent the structures recognised by IgE. An
allergenic molecule can have linear epitopes making up a
specific aminoacid sequence along its primary structure,
and conformational epitopes generated by the protein
folding. In order to better understand, we can think of an
allergenic molecule as a necklace as shown in figure 1: its
pearls represent the aminoacids. A linear epitope is made
by an aminoacid sequence (i.e. several pearls in a row),
and the specific IgE bind to the epitope after its recogni-
tion. A conformational epitope is made by aminoacids
that are in distant positions in the row but very close each
other when the necklace is folded.
Molecule foldings are essential for immunological sensiti-
zation induction and for the antibodies production. How-
ever many allergenic proteins, when exposed to heat or
digestion, can lose the conformational epitopes; thus the
molecule can be opened and the linear epitopes exposed
[5-8]. On these bases a theoretical classification has been
established for instance for food allergens: class 1 food
allergens and class 2 food allergens [9]. Class 1 food aller-
gens are digestion and heat resistant proteins; they are
able to act as sensitizers at the gastrointestinal level. They
can give moderate (oral allergy syndrome, OAS) to sys-
temic reactions [10]. Proteins of milk, eggs, fish, peanuts,
and some vegetables (containing LTP) are Class 1 food
allergens. Most of them are typical childhood allergens
(Table 1). Class 2 food allergens are mainly found in veg-
etables, but can also be present in animal derived foods.
They are not resistant to heat and digestion and are gener-
ally considered unable to cause systemic symptoms.
Sometimes they do not trigger symptoms at all. Patients
usually show mild symptoms restricted to the oropharyn-
geal cavity (OAS), and seem to be primary sensitized by
inhalant allergens. The subsequent reaction to plant foods
is based on the presence of homologous allergens in both
plant allergenic tissues: Bet v 1 proteins, profilins. They
are called "non sensitizing elicitors" (Table 2). This phe-
nomenon explains why some patients suffer from reac-
tions, sometimes severe, when they ingest allergenic foods
never ate before. Either the aminoacids sequence homol-
ogy or the presence of a similar epitope patch on the pro-
tein surface causes this phenomenon, usually called
"cross-reactivity", but better identified as "IgE co-recogni-
tion" [11].
It is not always possible to establish a priori which, among
two or more allergens, has been able to induce the IgE sen-
sitization (sensitizer) or the cross reactivity (elicitor).
Factors needed for proteins cross reactivity are:
1) the cross reactive portion of the epitopes;
2) the cross reactive portion of the IgE (paratope);
3) the affinity among the IgE and the two epitopes on
the two related allergens.
Conformational and sequential epitopes Figure 1
Conformational and sequential epitopes.
Table 1: Examples of Class 1 food allergens
Allergenic Sources Proteins Nomenclature
Cow's milk Caseins Bos d 8
Lactalbumin Bos d 4
Lactoglobulin Bos d 5
Egg's white Ovomucoid Gal d 1
Ovoalbumin Gal d 2
Peanut Vicilin Ara h 1
Conglutin Ara h 2
11S Globulin Ara h 3
Fish Parvalbumin Gad c 1
Cod
Plants Lipid Transfer Protein
Apple Mal d 3
Peach Pru p 3
(more details on http://www.allergome.org)Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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Antibody antigen recognition requires 6-8 aminoacids
placed on the linear sequence; two different proteins must
be at least 35% identical to determine cross reactivity [12],
but this should not be a rigid rule as there are several
exceptions.
Diagnosis with molecular allergens
In recent years molecular allergens have been produced
and commercialized. They have been obtained as highly
purified molecules by either recombinant DNA methods,
or by biochemical purification from natural sources. The
availability of highly pure allergenic molecules is easing
the production which can be standardized and large
amounts of allergens can be produced.
In the case of the recombinant allergens, it is possible to
introduce specific site mutations to generate hypoaller-
gens, and to clone isoforms.
It is not the purpose of this review to explain in details
how to perform specific IgE determinations towards aller-
genic extracts or allergens. However, it is enough to
remind that singleplex diagnostic tests (one result for a
single serum specimen [13]) are the same as those used
for the IgE determinations towards allergenic extracts, the
difference being that the antigen is a highly purified mol-
ecule, either natural or recombinant. Currently, using
multiplex diagnostic tests (several results for a single spec-
imen [13]) is possible to detect the presence of specific IgE
to 103 allergenic molecules, using 20 μl of serum. Each
assay is in triplicate, meaning that is repeated three times
for each single protein (ISAC system, VBC-Genomics, Aus-
tria) [14]. The total cost of one of these tests is lower than
the sum of the single determinations carried out with a
system in singleplex aiming to test an equal number of
allergens (Mari A et al. manuscript submitted).
Molecular allergens have shown a sensitivity greater than
80% in mimicking the allergenic sources [15]; such sensi-
tivity becomes proportionately higher by putting together
all single allergenic proteins coming from a single organ-
ism or tissue [15-17]. In order to understand the results
provided by these tests, it is important to know the clinical
and immunological meaning of the tested allergenic mol-
ecules. The nomenclature and the classification of the
main allergens is herein reported; for more detailed infor-
mation the Allergome web site http://www.allergome.org
is suggested [18].
Allergen nomenclature and classification
Allergen nomenclature has been officially defined by the
International Union of Immunological Societies Allergen
Nomenclature Subcommittee and reported in several doc-
uments [19-21] and currently updated and displayed on
the official web site: http://www.allergen.org. The allergen
nomenclature uses the first three letters from the organ-
ism genus name, followed by a single letter (sometimes
two) from the species name, and a number indicating the
order of identification of the allergen: e.g. Bet v 1, Bet
(genus: Betula) v (species: verrucosa) 1 (order of identifica-
tion, sometimes homologous groups). Exceptions to this
format and other definitions for isoforms, variants, pep-
tides, genes are given in the most updated document [21].
Definitions for isoforms and variants are reported in
Appendix 1 as they play a critical role in current diagnostic
and future immunotherapeutic use of allergens.
Allergen subsets can also be defined on the basis of the
clinical phenotype they can induce:
(a) "genuine allergens": proteins contained in a defined
allergenic source and those taxonomically closely related:
Ole e 1 is the allergen of the olive pollen, able to cross
react with other group 1 Oleaceae allergens (i.e. Fra e 1);
Phl p 1 and Phl p 5 represent the markers of grass pollen
group 1 and 5, and Cup a 1 is the allergen of Cupressaceae
group 1 (cedar/cypress/juniper); Par j 1, Par j 2 are aller-
gens of pellitory pollen; Der p 1, Der p 2, Der f 1, Der f 2
are named genuine dust mite allergens [22].
Table 2: Examples of Class 2 food allergens
Allergenic Sources Proteins Nomenclature
Apple Bet v 1-like proteins Mal d 1
Peach Pru p 1
Celery Api g 1
Hazelnut Cor a 1
Banana Chitinases Mus a Glucanase
Kiwi, golden Act c Chitinase
Kiwi, green Act d Chitinase
Tomato Lyc e Chitinase
Tomato Profilins Lyc e 1
Apple Mal d 4
Peach Pru p 4
Celery Api g 4
Hazelnut Cor a 2
(more details on http://www.allergome.org)Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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(b) Panallergens are proteins with a high similarity but not
identical, present in different botanical or zoological fam-
ilies, related and unrelated by taxonomy [23-27].
The panallergen distribution is broader than for genuine
allergens, explaining why they are not always uniformly
IgE recognized by 100% of the patients sensitized to
them.
Several panallergen groups have been described up to
now:
1) Bet v 1-like proteins (Fagales-related proteins), widely
distributed in the plant kingdom, are defence proteins,
belonging to the family of "pathogenesis-related proteins"
or PR-10; they are present in tissues devoted to reproduc-
tion (pollen, seeds, and fruits) [28]. They are molecules
not resistant to heat or digestion, and produced according
to the degree of maturity of plants and can cause symp-
toms by both inhalation and ingestion. The Bet v 1-like
proteins are present, in addition to the pollen of birch,
also in pollen of the Fagales family (i.e. beech, oak, chest-
nut, and hazel). These trees have different pollination sea-
son, causing in certain geographical areas the persistence
of symptoms by inhalation (i.e. rhino-conjunctivitis,
asthma) for several months, from January to June. In cen-
tral and southern regions of Italy, where the birch does
not spontaneously grow because of the climate, homolo-
gous species are present (hazel, oak, beech, chestnut).
They can cause sensitization to the same allergen group as
birch pollen. The correct understanding and interpreta-
tion of cross reactivity within the above described species
it possible taking into account their molecular relation-
ship [29]. Furthermore, patients allergic to birch pollen
suffer from allergic reactions when they eat various types
of fruit and vegetables sharing cross reactivity between Bet
v 1 and homologous allergens. These homologous aller-
gens are present in Rosaceae (i.e. apple, pear, peach and
some nuts), Apiaceae  (celery, carrot), Fabaceae  (soya
beans, peanuts). Symptoms caused by ingestion of Bet v 1-
like proteins contained in food are generally mild (class 2
food allergens). The OAS is an example, though more
severe reactions have been reported for soya [30-32]. To
date 48 Bet v 1-like allergens have been described.
2) Profilins are proteins present in all eukaryotic cells.
Those belonging to the plant kingdom have sequence
homology higher than 75%. 10-20% of pollen sensitized
patients (grass, birch, olive, pellitory) have IgE to profilins
[33]. When that happens the cross reactivity between pol-
len, vegetables and latex is extremely high. Profilins may
cause the same symptoms via inhalation, contact, inges-
tion as the Bet v 1-like proteins do (class 2 food allergens)
[34] though severe reactions caused by profilin exposure
have never been reported. To date 97 profilins have been
described as allergens.
3) The members of most ubiquitous family of Calcium
Binding Protein, also defined polcalcins to distinguish
them from other calcium binding protein, are pollen
components from trees (Bet v 4, Aln g 4, Ole e 3, Jun o 4),
grasses (Cyn d 7, Phl p 7) and weeds (Bra n 4, Bra n 7, Bra
r 4, Bra r 7, Par j 4).
They are cross-reactive allergens present in pollen. No sig-
nificant cross-reactivity has been found among the fish
parvalbumins and pollen calcium binding proteins [28].
Polcalcins are not present in edible parts of plants. Phl p
7 and Bet v 4 are considered markers of this group. The
extended allergen dispersal period caused by the polcalcin
release from many different pollen species (Table 3) can
cause persistent allergic respiratory symptoms not related
to flowering of a single allergenic source [27,35,36].
Severe asthma symptoms have been reported for this
group of molecule so far [33]. To date 39 polcalcins have
been described as allergens.
4)  Lipid Tranfer proteins (LTP) are true panallergens
with a variable degree of cross-reactivity. They are defence
plant proteins against the attack of bacteria, fungi, and
viruses. This has led them to be ubiquitously expressed
throughout the plant kingdom [28]. The highest expres-
sion levels have been found in peripheral cells associated
with cell wall and cuticle of epidermal tissues. Due to their
resistance to pepsin digestion and to heat, LTP are consid-
ered food allergens which might cause severe reactions
(class 1 food allergens). After ingestion, but occasionally
also by inhalation or contact, symptoms include all the
clinical pictures described for a food IgE mediated reac-
tion up to now, starting from OAS to gastrointestinal
symptoms characterized by violent intestinal cramps, or
to urticaria-angioedema syndrome, up to anaphylaxis.
Our data, collected in a population of more than 30,000
patients, shows that LTP allergy can be present at any age.
A relevant number of this patients experience fruit allergy
without linked pollinosis (Mari A et al., manuscript in
preparation). Cross-reactivity among allergenic LTP
present in food has been described, even between mem-
bers of botanically unrelated species (Table 4). There are
no longitudinal studies establishing whether a patient will
be monosensitized all lifelong or will develop multiple
sensitizations within this group of panallergens. However,
sensitization (detection of specific IgE) does not mean
clinical allergy (e.g. symptoms on exposure), and fruits or
vegetables containing LTP should be avoided only if
important symptoms occur after current exposure. The
concentration of LTP in fruit varies depending on the mol-
ecule localization. Patients sensitized to peach LTP eating
peach once peeled are reported. To date 36 LTP acting as
allergens by ingestion have been described.
5)  Seed storage proteins make the required nutrients
available to plant seeds during sprouting. They includeItalian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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groups of proteins such as the 11S globulins, 2S albumins
and the 7S vicilins, widely present in the majority of aller-
genic seeds: mustard, walnuts, sesame, castor bean,
cashew, pistachio, peanuts [12,28]. They are resistant to
cooking and digestion (class 1 food allergens). Seed stor-
age proteins are first among the food allergens to be
responsible for severe anaphylactic reactions in adults. In
the child instead, they are ranked third following milk and
egg allergens. To date 66 seed storage proteins acting as
allergens have been described.
6) Tropomyosins regulate muscle contraction in inverte-
brates. Exposure to the allergenic sources containing these
proteins occurs on a daily basis, as these proteins are wide-
spread in animal species. They have been identified as
inhalant allergens (mites, cockroaches) and as food aller-
gens (crustaceans, molluscs, and a fish parasite Anisakis
simplex) (Table 5). Their presence in the house dust is pro-
portional to the quantity of arthropods infesting house
(mites, spiders, silverfishes, cockroaches) [37]. Tropomy-
osins retain their IgE binding ability even after prolonged
heating or gastric proteolysis. The frequent cross-sensitiza-
tion among different allergenic sources is due to the
highly conserved tropomyosin sequences. Running the
diagnostic tests with allergenic extracts might lead to pos-
itive results for mites, cockroaches, and shellfishes, since
these panallergens are contained in all those sources.
Missing the IgE molecular profile, it will be impossible to
find out whether the mite allergic patient is sensitized to
this type of allergen (Der p 10) or to the genuine one from
the dust mites (Der p 1, Der p 2). To date 111 tropomy-
osins have been described as allergens. Eleven tropomy-
osins are IgE-binding proteins in parasites, mainly
nematodes.
Table 3: Polcalcins
Allergens Species Common name
Aln g 4 Alnus glutinosa Alder
Amb a 10 Ambrosia artemisiifolia Ragweed
Amb a 9
Art v 5 Artemisia vulgaris Mugwort
Bet v 3 Betula verrucosa Birch
Bet v 4
Bra n 4 Brassica napus Rapeseed
Bra n 2
Bra r 4 Brassica rapa Turnip
Bra r 7
Che a 3 Chenopodium album Goosefoot
Cup a 4 Cupressus arizonica Cypress
Cyn d 7 Cynodon dactylon Bermuda grass
Jun o 4 Juniperus oxycedrus Cedar
Ole e 3 Olea europea Olive tree
Ole e 8
Ory s 7 Oryza sativa Rice
Phl p 7 Phleum pratense Timothy Grass
Syr v 3 Syringa vulgaris Common Lilac
(more details on http://www.allergome.org)
Table 4: Vegetables containing LTP
Allergens Food Allergens Food
All c 3 Onion Lyc e 3 Tomato
Ara h 9 Peanut Mal d 3 Apple
Aspa o 1 Asparagus Ory s 14 Rice
Bra o 3 Broccoli Pru ar 3 Apricot
Bra r 3 Turnip Pru av 3 Cherry
Cas s 8 Chestnut Pru d 3 Plum
Cit l 3 Lemon Pru du 8 Almond
Cit r 3 Mandarin Pru p 3 Peach
Cit s 3 Orange Pun g 3 Pomegranate
Cor a 8 Hazelnut Pyr c 3 Pear
Dau c 3 Carot Ros r 3 Rose
Fra a 3 Strawberry Rub i 3 Raspberry
Hel a 3 Sunflower Tri a 14 Wheat
Hor v 14 Barley Tri s 14 Spelt
Jug r 3 Walnut Vit v 1 Grape
Lac s 1 Lettuce Zea m 14 Corn
(more details on http://www.allergome.org)Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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8)  Parvalbumins  represent a large group of proteins
involved in muscular contraction controlling calcium
flow in the muscular sarcoplasm. It has been demon-
strated that they are present in white muscle of many fish
species; thus, cross-reactivity among different fish species
do exist. However, patients allergic to some fish can some-
time ingest some other species without risk of allergic
symptoms [38,39]. Parvalbumins from fishes and frogs
are major food allergens eliciting IgE responses in most
fish-allergic individuals [40-42]. Resistance to boiling and
enzymes of the gastrointestinal tract may thus allow this
allergen to sensitize patients. To date 39 parvalbumins
acting as allergens have been described.
9) Chitinases and glucanases
The outstanding relevance of molecular diagnosis is fur-
ther exemplified by the understanding of the latex allergic
patient profiling. The IUIS web site lists 13 natural rubber
latex allergens characterized at the molecular level. Hev b
1, rubber elongation factor, Hev b 3, small rubber particle
protein, Hev b 4, microhelix component, Hev b 6, prohev-
ein/hevein, and Hev b 5 (structural protein) are the major
allergens recognized by latex-sensitized patients [43,44].
A significant proportion (close to 30-50%) of the patients
experiencing allergy to latex shows signs of associated
hypersensitivity to various fresh fruits (avocado, banana,
chestnut, passion fruit, papaya, tomato, mango, bell-pep-
per, potato and kiwi) containing homologous molecules
without previous sensitization to the fruit proteins. [45-
47]. The main molecular allergens responsible of this syn-
drome are: Hev b 2 (β-1,3-glucanase) [48], Hev b 7 (pata-
tin-like protein) [49], Hev b 8 (Profilins) [44], and overall
Hev b 6 (hevein-like domain) [48] (Table 6).
Hev b 2 (PR-2 type proteins) are enzymes widely distrib-
uted in plants included into pathogenesis-related protein
(proteins able to improve the defence mechanisms of
plants against pathogens) [50], produced by several vege-
table organs such as seeds, roots, leaves, fruits. The major
allergens of latex, Hev b 2 (1,3-β glucanase) has been asso-
ciated with hypersensitivity to foods, especially avocado,
banana, chestnut, fig, and kiwi [51,52] and patatin from
potato, showed IgE cross-reactivity with bell-pepper [53]
and potato [49].
Hev b 6 prohevein (Hev b 6.01) and hevein (Hev b 6.02)
has structural homologies with some cereal lectins [54]
and other plant lectins and chitin-binding proteins [55].
Chitinases  (class I chitnases, PR-3 type proteins) are
defence enzymes against moulds and insects [56] acting
towards chitin that is a structural component of the
exoskeleton of insects and the cell walls of most fungi.
They contain a hevein N-terminal domain of about 40
amino acid residues with putative chitin binding proper-
ties. Their allergenic activity is inactivated by heat whereas
enhanced by artificial fruit ripening [57]. Chestnut (Cas-
tanea sativa), avocado (Persea americana) [46,58] and
banana [59] belong to this group. Another family of chiti-
nases (PR- 4 type proteins induced in potato, tobacco and
in turnip (Brassica rapa) in response to wounding, lacks
the N-terminal hevein domain [60,61]. The latex aller-
genic proteins represent the sensitizing allergens, whereas
the fruit chitinases are the elicitors (class 2 food allergens).
Disadvantages of using allergenic extracts
An allergenic extract is commonly used for ST or for in
vivo specific IgE determination or for specific immuno-
therapy. Allergenic extracts have some disadvantages that
are important to know:
a) Allergen loss
Some fruit proteins are soluble in acid or in basic solu-
tion: the extraction of one protein soluble in acid solution
causes the loss of the other proteins soluble in basic solu-
tion, and vice versa as reported for peach allergens by
Ahrazem et al [62].
Some allergens are present in very low concentration (e.g.
allergen from Cypress pollen grains) or can be destroyed
because of the enzymatic activity of the extract [63].
Some allergens, even though responsible for systemic
reactions, can be absent from the allergenic extracts, as
reported for hazelnut LTP [64].
Other disadvantages in using allergenic extracts are the
possible batch to batch variations in protein and allergen
concentrations, unless the preparations come from the
same manufacturer. Thus, there is a lack quantification
(i.e. μg/ml) of the allergenic proteins present in the extract
[65,66].
Twenty-three allergenic proteins have been described in
Dermatophagoides pteronyssinus (an allergenic source).
However the presence and amount of all these proteins
within any relevant extract are unknown. Very recently,
the presence of some major allergens for some allergenic
extracts has been stated by the pharmaceutical companies,
but the presence of minor ones has never been reported,
which might even be absent [64].
Lack of allergenic proteins or their low concentration
could cause wrong negative diagnosis with consequent
ineffective immunotherapy.
b) Presence of unwanted allergenic sources
During extraction procedures some relevant allergenic
proteins can be lost, whereas others coming from different
allergenic sources can contaminate the extract as they were
present in the starting raw material used for the extraction.Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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Table 5: Tropomyosins
Allergens Sources
Pen i 1 Fenneropenaeus indicus Shrimps Crustaceans
Pen a 1 Farfantepenaeus aztecus
Pan s 1 Panulirus stimpsoni
Met e 1 Metapenaeus ensis
Hom a 1 Homarus americanus Lobster
Cha f 1 Charybdis feriatus Crab
Ani s 3 Anisakis simplex Worms Nematode
Asc s 3 Ascaris lumbricoides
Bla g 7 Blattella germanica Cockroaches Insects
Per a 7 Periplaneta americana
Per f 7 Periplaneta fuliginosa
Chi k 10 Chironomus kiiensis Midge
Lep s 1 Lepisma saccharina Silverfish
Dro m 7 Drosophila melanogaster Fly
Blo t 10 Blomia tropicalis Mites
Der f 10 Dermatophagoides farinae
Der p 10 Dermatophagoides pteronyssinus
Der g 10 Dermanyssus gallinae
Lep d 10 Lepidoglyphus destructor
Tyr p 10 Tyrophagus putrescentiae
Cra g 1 Crassostrea gigas Oyster Molluscs
Hal d 1 Haliotis diversicolor Abalone
Hel as 1 Helix aspersa Snail
Tur c 1 Batillus cornutus Mussels
Myt e 1 Mytilus edulis
Myt g 1 Mytilus galloprovincialis
Oct v 1 Octopus vulgaris Octopus
Mim n 1 Mimachlamys nobilis ClamsItalian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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That is the case of some dog's allergenic extracts causing
false positive ST in mite-sensitized patients because of the
contamination of mite allergens in dog's epithelium, thus
leading to a wrong diagnosis [67].
c) Perception of multiple sensitizations
The allergenic extracts do not allow the description of
multiple sensitisations towards different allergens in
patients with positive ST or specific IgE; they do not allow
understanding if multiple sensitisation is due to IgE to dis-
tinct allergenic molecules (co-sensitization) or rather to a
co-recognition (sensitization towards different allergenic
sources, including the same allergenic molecules). As an
example, a child suffering from food allergy, with a posi-
tive skin prick test to hazelnut extract might have a very
different prognosis if the sensitization is linked to a Bet v
Per v 1 Perna viridis
Sep l 1 Sepioteuthis arctipinnis Golden Cuttlefish
(more details on http://www.allergome.org)
Table 5: Tropomyosins (Continued)
Table 6: Allergens linking latex allergy to fruit reactivity
Sensitizer Elicitors
Source Allergen Common names Sources Name
Latex Hev b 2 Glucanase Olive tree Ole e 9
Bell Pepper Cap a Glucanase
Hev b 6 Hevein-like Domain Turnip Bra r 2
Obeche Trip s 1
Banana Mus xp Chitinases
Mus xp Hevein
Acerola Mal g Hevein
Avocado Pers a 1
Pers a Hevein
Hev b 11 Chitinases Class 1 Kiwi Act c Chitinase
Act d Chitinase
Tomato Lyc e Chitinase
Chestnut Cas s 5
Hev b 7 Potato Sola t 1
Hev b 8 Profillin Mugwort Amb a 8
Birch Bet v 2
Bell Pepper Cap a 2
Goosefoot Che a 2
(more details on http://www.allergome.org)Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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1-like protein or to a seed storage protein or to a lipid
transfer protein. In the first case he does not run any risk
of serious anaphylactic reaction, in the second and third
case he should always carry auto-injectable epinephrine.
In each case a different pattern of cutaneous reactivity
could be recorded without being possible to understand
the intimate sensitization profile. Moreover what said
before is really a frustrating limit for the allergist, when
deciding to prescribe a specific immunotherapy or an
elimination diet in case of food allergy.
However, a patient characterized by allergy to a source
might not show any symptoms towards cross reacting
allergens, even in case of positive ST or specific IgE for
those allergens is present. The reason for this phenome-
non is not known yet [23,24,68].
Advantages in using molecular allergens during the 
paediatric age
The number of purified recombinant or natural molecular
allergens is in rapid increase, allowing to acquire more
and more comprehensive and detailed information on
child's sensitization profile [69].
Today it is possible, and it will be even easier in the future,
to develop peptide sequences (peptide-chips) to describe
the ultrafine IgE reactivity pattern of each patient. All
these information will provide the overall and in depth
description of the specific and antigenic features of the
involved epitopes. The knowledge of the whole pattern of
IgE responses will help to better understand the pathogen-
esis of allergic disease [69,70].
The application of micro-technology [14] and molecular
allergens is leading to new methods for studying single
patient's IgE co-recognition of homologous allergens
[71,72].
Molecular diagnosis allows us to look forward the availa-
bility of a new specific immunotherapy, not based on
undefined extracts anymore, but tailored on the single
patient sensitization.
So far, not all allergenic sources have been completely
characterized, and therefore the molecular diagnosis is
not able to completely replace the allergenic extracts yet.
All the different methods must complement and complete
each other [15].
Knowledge of true offender protein contained in a food or
in an inhalant allergenic source and relevant physico-
chemical properties can allow primary and secondary pre-
vention during the paediatric age. Should a child suffer
from food anaphylaxis due to a certain protein, we could
first of all prevent a new reaction by excluding from the
diet not only that kind of food but also all the allergenic
sources containing homologous proteins [73-75]. As a
second step, some of the excluded foods containing
homologous molecules having a low level of amino acid
identity could then be reintroduced after specific chal-
lenge tests, to be carried out in a controlled setting. This
could be done in a better and safer way if we can also test
the molecule panel of interest by either ST or specific IgE
reactivity. Moreover, taking into account the protein struc-
tural changes induced by heat and digestion, tolerance to
cooked egg might be tested by some children allergic to
raw egg [76], whereas tolerance to well done steak might
be shown by some children allergic to underdone meat
[7]. This could be easily reached when sensitization to
heat labile allergenic epitopes is diagnosed. As a final
example we can mention the case of a child suffering from
oral allergic syndrome induced by nuts. As many children
do, he is fond of Nutella, a delicious Italian hazelnut
spread. Allowing or forbidding Nutella to such a child can
be decided only upon exact knowledge of his allergenic
molecule profile. In case of sensitization to Bet v 1-like
proteins, or to profilins, Nutella might be allowed,
whereas in case of sensitization to seed storage protein or
to lipid transfer protein Nutella must be totally forbidden
[77]. All above examples are not trivial, as they demon-
strate the relevance of an appropriate planning of a correct
diet for an allergic child, mainly in case of poly-sensitiza-
tion. Paediatricians have to provide patients not only with
the essential nutrients, but also with an optimised quality
of life. As a matter of fact, useless forbiddances could only
add marginalisation in a child or even rejection in a young
adolescent. Furthermore, it is well known that asthma
begins in childhood [78,79] and a good asthma preven-
tion in a sensitized child might be reached by allergen
detection and avoidance of true relevant exposure [80].
This can hold true for all the allergic diseases where aller-
gen avoidance can be applied.
Conclusion
The diagnosis using allergen extracts can be helpful iden-
tifying sensitization to a particular allergen source, but
cannot resolve the molecular identity of the disease-elicit-
ing allergen.
On the opposite, allergenic molecules allow the definition
of a more precise patient's sensitization profile: if he or
she is allergic to a genuine allergen, to major or minor
determinant, or to a cross-reactive protein. Nowadays it is
no more possible to test a patient with a huge number of
allergenic extracts and feel satisfied because "...those are the
extracts commonly recognized by the majority of the popula-
tion". We still know too little to establish such limits, and
there is no correlation between what is measured by epi-
demiological studies and what happens in a single
patient. A single patient might also be a rare case (case
report from the literature) but that rare case, that rare
allergy, still represents 100% of the life of that patient, andItalian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
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of the diagnosis of that allergist. The rarity is also propor-
tional to the prevalence of a measured phenomenon. A
multiplex test using recombinant or natural purified aller-
genic molecules allows testing many allergens, with low
costs and low serum volume required. This approach let
reaching an insight as broad as possible on all the aller-
gens recognized by a single patient.
Paediatrics is a branch of medical care dealing with assist-
ance of infant, child, adolescent. The upper age limit
ranges from age 14 to 18, depending on the country.
Metabolism and immune system are age dependent.
Infants, children, adolescents all live in the adults world,
all breath the same allergenic molecules, all eat the same
food allergens and at any time of their life they might
become allergic. Until now no study has been performed
to catch the sensitizing moment or to explain why an
allergen is "stronger" than another one. A better under-
standing of these matters will be possible by following
large paediatric population for years and searching for
sensitizations by means of a multiple allergen array.
From all the above, it should be evident why even a non-
allergist paediatrician needs to acquire the basic tools of
this new knowledge. It is fundamental to continue to fol-
low and correctly advise the little patients, staying in step
with the times.
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Appendix 1
Isoallergen and Variant Definitions
Isoallergen
Similar molecules may be contained in a single allergenic
source. They are named isoallergens when they divide
similar molecular size, identical biologic function, if
known, (e.g., enzymatic action), ≥ 67% identity of amino
acid sequences.
Nevertheless, the recommended 67% identity in ami-
noacid sequence (http://www.allergome.org, Aller-
gomeBlaster tool [18]) is only a guide with a lot of
borderline cases[21].
Variants
Nucleotide mutations, either silent or leading to single or
multiple amino acid substitutions can appear in the com-
plementary DNA cloning of allergens causing single or
multiple substitutions of aminoacids which generate var-
iants. Therefore each isoallergen presents multiple forms
of the same similar sequence, defined variants (identity
greater than 95%).
Isoallergens and their variants belonging to the same
allergen group are designated by suffixes of a period fol-
lowed by four Arabic numerals. The first two numerals, 01
to 99, refer to a particular isoallergen; the two subsequent
numerals, 01 to 99, refer to a particular variant of a partic-
ular isoallergen designated by the preceding two numerals
e.g. Bet v 1.01 01 [21].
Acknowledgements
This review article has been made possible by a funding of the Italian Min-
istry of Health to research hospitals (IRCCS), Current research project 
2008.
Note
Data on allergens have been obtained from the Allergome platform http://
www.allergome.org on July 2009.
References
1. Cohen SG, King JR: Skin Tests: A Historic Trail.  Immunol Allergy
Clin North Am 2001, 21:191-249.
2. Johansson SG: Raised levels of a new immunoglobulin class
(IgND) in asthma.  Lancet 1967, 2:951-3.
3. Wide L, Bennich H, Johansson SG: Diagnosis of allergy by an in-
vitro test for allergen antibodies.  Lancet 1967, 2:1105-7.
4. Mari A: When does a protein become an allergen? Searching
for a dynamic definition based on most advanced technology
tools.  Clin Exp Allergy 2008, 38:1089-94.
5. Lopez-Exposito I, Chicon R, Belloque J, Recio I, Alonso E, Lopez-
Fandino R: Changes in the Ovalbumin Proteolysis Profile by
High Pressure and Its Effect on IgG and IgE Binding.  J Agric
Food Chem 2008, 56:11809-16.
6. Yoshino K, Sakai K, Mizuha Y, Shimizuike A, Yamamoto S: Peptic
digestibility of raw and heat-coagulated hen's egg white pro-
teins at acidic pH range.  Int J Food Sci Nutr 2004, 55:635-40.
7. Fiocchi A, Restani P, Riva E, Mirri GP, Santini I, Bernardo L, Galli CL:
Heat treatment modifies the allergenicity of beef and bovine
serum albumin.  Allergy 1998, 53:798-802.
8. Jin T, Guo F, Chen YW, Howard A, Zhang YZ: Crystal structure of
Ara h 3, a major allergen in peanut.  Mol Immunol 2009,
46:1796-804.
9. Sampson HA: Food allergy.  J Allergy Clin Immunol 2003,
111:S540-S547.
10. Egger M, Mutschlechner S, Wopfner N, Gadermaier G, Briza P, Fer-
reira F: Pollen-food syndromes associated with weed pollino-
sis: an update from the molecular point of view.  Allergy 2006,
61:461-76.
11. Ferreira F, Hawranek T, Gruber P, Wopfner N, Mari A: Allergic
cross-reactivity: from gene to the clinic.  Allergy 2004,
59:243-67.
12. Hauser M, Egger M, Wallner M, Wopfner N, Schmidt G, Ferreira F:
Molecular Properties of Plant Food Allergens: A Current
Classification into Protein Families.  Open Immunol J 2008,
1:1-12.
13. Matsson PNJ, Hamilton RG, Esch RE, Halsey JF, Homburger HA,
Kleine-Tebbe J, Mari A, Ownby DR, Reeves JP, Renz H, Vogt RF Jr,
Williams PB: Analytical Performance Characteristics and Clin-
ical Utility of Immunological Assays for Human Immu-
noglobulin E (IgE) Antibodies and Defined Allergen
Specificities; Approved Guideline--Second Edition.  CLSI docu-
ment I/LA20-A2 2009, 29:1-145.Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
Page 11 of 12
(page number not for citation purposes)
14. Harwanegg C, Hiller R: Protein microarrays for the diagnosis of
allergic diseases: state-of-the-art and future development.
Clin Chem Lab Med 2005, 43:1321-6.
15. Zennaro D, Palazzo P, Pomponi D, Helmer-Citterich M, Costanzi G,
Zaffiro A, Quaratino D, Giani M, Scala E, Afeltra A, Mari A: Retro-
spective comparative analysis of skin test and IgE reactivity
to extracts, and singleplexed or multiplexed allergenic mol-
ecules.  Allergy 2007, 62:S153.
16. Ballmer-Weber BK, Scheurer S, Fritsche P, Enrique E, Cistero-Bahima
A, Haase T, Wuthrich B: Component-resolved diagnosis with
recombinant allergens in patients with cherry allergy.  J Allergy
Clin Immunol 2002, 110:167-73.
17. Fernandez-Rivas M, Gonzalez-Mancebo E, Rodriguez-Perez R, Benito
C, Sanchez-Monge R, Salcedo G, Alonso D, Rosado A, Tejedor MA,
Vila C, Casas ML: Clinically relevant peach allergy is related to
peach lipid transfer protein, Pru p 3, in the Spanish popula-
tion.  J Allergy Clin Immunol 2003, 112:789-95.
18. Mari A, Rasi C, Palazzo P, Scala E: Allergen databases: current
status and perspectives.  Curr Allergy Asthma Rep 2009, 9:376-83.
19. Chapman MD, Pomes A, Breiteneder H, Ferreira F: Nomenclature
and structural biology of allergens.  J Allergy Clin Immunol 2007,
119:414-20.
20. Larsen JN: Allergen Nomenclature: A need for the scientific
community.  Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A
M 2006, 95:5-10.
21. King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Tho-
mas W: Allergen Nomenclature.  J Allergy Clin Immunol 1995,
96:5-14.
22. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D,
Valenta R: Recombinant marker allergens: diagnostic gate-
keepers for the treatment of allergy.  Int Arch Allergy Immunol
2002, 127:259-68.
23. Aalberse RC: Assessment of allergen cross-reactivity.  Clin Mol
Allergy 2007, 5:1-6.
24. Aalberse RC, Akkerdaas J, van Ree R: Cross-reactivity of IgE anti-
bodies to allergens.  Allergy 2001, 56:478-90.
25. Wopfner N, Gruber P, Wallner M, Briza P, Ebner C, Mari A, Richter
K, Vogel L, Ferreira F: Molecular and immunological character-
ization of novel weed pollen pan-allergens.  Allergy 2008,
63:872-81.
26. Radauer C, Breiteneder H: Pollen allergens are restricted to few
protein families and show distinct patterns of species distri-
bution.  J Allergy Clin Immunol 2006, 117:141-7.
27. Ledesma A, Barderas R, Westritschnig K, Quiralte J, Pascual CY,
Valenta R, Villalba M, Rodriguez R: A comparative analysis of the
cross-reactivity in the polcalcin family including Syr v 3, a
new member from lilac pollen.  Allergy 2006, 61:477-84.
28. Radauer C, Bublin M, Wagner S, Mari A, Breiteneder H: Allergens
are distributed into few protein families and possess a
restricted number of biochemical functions.  J Allergy Clin Immu-
nol 2008, 121:847-52.
29. Mari A, Wallner M, Ferreira F: Fagales pollen sensitization in a
birch-free area: a respiratory cohort survey using Fagales
pollen extracts and birch recombinant allergens (rBet v 1,
rBet v 2, rBet v 4).  Clin Exp Allergy 2003, 33:1419-28.
30. Bohle B: The impact of pollen-related food allergens on pollen
allergy.  Allergy 2007, 62:3-10.
31. Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E, Asero R, van
Leeuwen A, Bohle B, Ma Y, Ebner C, Rigby N, Sancho AI, Miles S,
Zuidmeer L, Knulst A, Breiteneder H, Mills C, Hoffmann-Sommergru-
ber K, van Ree R: Apple allergy across Europe: How allergen
sensitization profiles determine the clinical expression of
allergies to plant foods.  J Allergy Clin Immunol 2006, 118:481-8.
32. Kleine-Tebbe J, Vogel L, Crowell DN, Haustein UF, Vieths S: Severe
oral allergy syndrome and anaphylactic reactions caused by
a Bet v 1- related PR-10 protein in soybean, SAM22.  J Allergy
Clin Immunol 2002, 110:797-804.
33. Mari A: Multiple pollen sensitization: a molecular approach to
the diagnosis.  Int Arch Allergy Immunol 2001, 125:57-65.
34. Mari A, Ballmer-Weber BK, Vieths S: The oral allergy syndrome:
improved diagnostic and treatment methods.  Curr Opin Allergy
Clin Immunol 2005, 5:267-73.
35. Wopfner N, Dissertori O, Ferreira F, Lackner P: Calcium-Binding
Proteins and Their Role in Allergic Diseases.  Immunol Allergy
Clin North Am 2007, 27:29-44.
36. Tinghino R, Twardosz A, Barletta B, Puggioni EM, Iacovacci P, But-
teroni C, Afferni C, Mari A, Hayek B, Di Felice G, Focke M,
Westritschnig K, Valenta R, Pini C: Molecular, structural, and
immunologic relationships between different families of
recombinant calcium-binding pollen allergens.  J Allergy Clin
Immunol 2002, 109:314-20.
37. Jeong KY, Hong CS, Yong TS: Allergenic tropomyosins and their
cross-reactivities.  Protein Pept Lett 2006, 13:835-45.
38. de Martino M, Peruzzi M, de Luca M, Amato AG, Galli L, Lega L, Azzari
C, Vierucci A: Fish allergy in children.  Ann Allergy 1993, 71:159-65.
39. Helbling A, Haydel R Jr, McCants ML, Musmand JJ, El Dahr J, Lehrer
SB: Fish allergy: is cross-reactivity among fish species rele-
vant? Double- blind placebo-controlled food challenge stud-
ies of fish allergic adults.  Ann Allergy Asthma Immunol 1999,
83:517-23.
40. Swoboda I, Bugajska-Schretter A, Linhart B, Verdino P, Keller W,
Schulmeister U, Sperr WR, Valent P, Peltre G, Quirce S, Douladiris
N, Papadopoulos NG, Valenta R, Spitzauer S: A Recombinant
Hypoallergenic Parvalbumin Mutant for Immunotherapy of
IgE-Mediated Fish Allergy.  J Immunol 2007, 178:6290-6.
41. Bugajska-Schretter A, Pastore A, Vangelista L, Rumpold H, Valenta R,
Spitzauer S: Molecular and immunological characterization of
carp parvalbumin, a major fish allergen.  Int Arch Allergy Immunol
1999, 118:306-8.
42. Dory D, Chopin C, Aimone-Gastin I, Gueant JL, Guerin L, Sainte-
Laudy J, Moneret-Vautrin DA, Fleurence J: Recognition of an
extensive range of IgE-reactive proteins in cod extract.
Allergy 1998, 53:42-50.
43. Yeang HY: Natural rubber latex allergens: new developments.
Curr Opin Allergy Clin Immunol 2004, 4:99-104.
44. Breiteneder H, Scheiner O: Molecular and immunological char-
acteristics of latex allergens.  Int Arch Allergy Immunol 1998,
116:83-92.
45. Diaz-Perales A, Collada C, Blanco C, Sanchez-Monge R, Carrillo T,
Aragoncillo C, Salcedo G: Cross-reactions in the latex-fruit syn-
drome: A relevant role of chitinases but not of complex
asparagine-linked glycans.  J Allergy Clin Immunol 1999, 104:681-7.
46. Diaz-Perales A, Collada C, Blanco C, Sanchez-Monge R, Carrillo T,
Aragoncillo C, Salcedo G: Class I chitinases with hevein-like
domain, but not class II enzymes, are relevant chestnut and
avocado allergens.  J Allergy Clin Immunol 1998, 102:127-33.
47. Blanco C, Diaz-Perales A, Collada C, Sanchez-Monge R, Aragoncillo
C, Castillo R, Ortega N, Alvarez M, Carrillo T, Salcedo G: Class I
chitinases as potential panallergens involved in the latex-
fruit syndrome.  J Allergy Clin Immunol 1999, 103:507-13.
48. Barre A, Culerrier R, Granier C, Selman L, Peumans WJ, Van Damme
EJM, Bienvenu F, Bienvenu J, Rouge P: Mapping of IgE-binding
epitopes on the major latex allergen Hev b 2 and the cross-
reacting 1,3[beta]-glucanase fruit allergens as a molecular
basis for the latex-fruit syndrome.  Mol Immunol 2009,
46:1595-604.
49. Schmidt MH, Raulf-Heimsoth M, Posch A: Evaluation of patatin as
a major cross-reactive allergen in latex- induced potato
allergy.  Ann Allergy Asthma Immunol 2002, 89:613-8.
50. Midoro-Horiuti T, Brooks EG, Goldblum RM: Pathogenesis-
related proteins of plants as allergens.  Ann Allergy Asthma Immu-
nol 2001, 87:261-71.
51. Blanco C, Carrillo T, Castillo R, Quiralte J, Cuevas M: Avocado
hypersensitivity.  Allergy 1994, 49:454-9.
52. Brehler R, Theissen U, Mohr C, Luger T: "Latex-fruit syndrome":
frequency of cross-reacting IgE antibodies.  Allergy 1997,
52:404-10.
53. Wagner S, Breiteneder H: Hevea brasiliensis Latex Allergens:
Current Panel and Clinical Relevance.  Int Arch Allergy Immunol
2004, 136:90-7.
54. Beezhold DH, Kostyal DA, Sussman GL: IgE epitope analysis of
the hevein preprotein; a major latex allergen.  Clin Exp Immunol
1997, 108:114-21.
55. Kurup VP, Kelly T, Elms N, Kelly K, Fink J: Cross-reactivity of food
allergens in latex allergy.  Allergy Proc 1994, 15:211-6.
56. Diaz-Perales A, Sanchez-Monge R, Blanco C, Lombardero M, Carillo
T, Salcedo G: What is the role of the hevein-like domain of
fruit class I chitinases in their allergenic capacity?  Clin Exp
Allergy 2002, 32:448-54.
57. Sanchez-Monge R, Blanco C, Perales AD, Collada C, Carrillo T, Arag-
oncillo C, Salcedo G: Class I chitinases, the panallergensPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Italian Journal of Pediatrics 2009, 35:29 http://www.ijponline.net/content/35/1/29
Page 12 of 12
(page number not for citation purposes)
responsible for the latex-fruit syndrome, are induced by eth-
ylene treatment and inactivated by heating.  J Allergy Clin Immu-
nol 2000, 106:190-5.
58. Sowka S, Hsieh LS, Krebitz M, Akasawa A, Martin BM, Starrett D,
Peterbauer CK, Scheiner O, Breiteneder H: Identification and
cloning of Prs a 1, a 32-kDa endochitinase and major allergen
of avocado, and its expression in the yeast Pichia pastoris.  J
Biol Chem 1998, 273:28091-7.
59. Sanchez-Monge R, Blanco C, Diaz-Perales A, Collada C, Carrillo T,
Aragoncillo C, Salcedo G: Isolation and characterization of
major banana allergens: identification as fruit class I chiti-
nases.  Clin Exp Allergy 1999, 29:673-80.
60. Hanninen AR, Mikkola JH, Kalkkinen N, Turjanmaa K, Ylitalo L,
Reunala T, Palosuo T: Increased allergen production in turnip
(Brassica rapa) by treatments activating defense mecha-
nisms.  J Allergy Clin Immunol 1999, 104:194-201.
61. Hanninen AR, Kalkkinen N, Mikkola JH, Helin J, Turjanmaa K, Reunala
T, Palosuo T: Prohevein-like defense protein of tobacco is a
cross-reactive allergen for latex-allergic patients.  J Allergy Clin
Immunol 2000, 106:778-9.
62. Ahrazem O, Jimeno L, Lopez-Torrejon G, Herrero M, Espada JL,
Sanchez-Monge R, Duffort O, Barber D, Salcedo G: Assessing aller-
gen levels in peach and nectarine cultivars.  Ann Allergy Asthma
Immunol 2007, 99:42-7.
63. Mari A, Di Felice G, Afferni C, Barletta B, Tinghino R, Sallusto F, Pini
C:  Assessment of skin prick test and serum specific IgE
detection in the diagnosis of Cupressaceae pollinosis.  J Allergy
Clin Immunol 1996, 98:21-31.
64. Akkerdaas JH, Wensing M, Knulst AC, Krebitz M, Breiteneder H, De
Vries S, Penninks AH, Aalberse RC, Hefle SL, van Ree R: How accu-
rate and safe is the diagnosis of hazelnut allergy by means of
commercial skin prick test reagents?  Int Arch Allergy Immunol
2003, 132:132-40.
65. Larsen JN, Dreborg S: Standardization of allergen extracts.
Methods Mol Med 2008, 138:133-45.
66. Focke M, Marth K, Valenta R: Molecular composition and biolog-
ical activity of commercial birch pollen allergen extracts.  Eur
J Clin Invest 2009, 39:429-36.
67. Veen MJ Van Der, Mulder M, Witteman AM, van Ree R, Aalberse RC,
Jansen HM, Zee JS Van Der: False-positive skin prick test
responses to commercially available dog dander extracts
caused by contamination with house dust mite (Dermat-
ophagoides pteronyssinus) allergens.  J Allergy Clin Immunol 1996,
98:1028-34.
68. Aalberse RC, Stadler BM: In silico predictability of allergenicity:
From amino acid sequence via 3-D structure to allergenicity.
Mol Nutr Food Res 2006, 50:625-7.
69. Scala E, Quaratino D, Zaffiro A, Bernardi ML, Ferrara R, Zennaro D,
Fantini R, Palazzo P, Giani M, Mari A: IgE proteomic in the diag-
nosis and epidemiology of allergic diseases: a population sur-
vey.  Allergy 2007, 62:S432.
70. Scala E, Pomponi D, Guerra EC, Locanto M, Mondino C, Pirrotta L,
Guarnaccia G, Giani M, Mari A: Homologous molecules IgE co-
recognition revealed by testing on an allergenic molecule
microarray system.  Allergy 2007, 62:S53.
71. Gadermaier G, Harrer A, Girbl T, Palazzo P, Himly M, Vogel L, Briza
P, Mari A, Ferreira F: Isoform identification and characteriza-
tion of Art v 3, the lipid-transfer protein of mugwort pollen.
Mol Immunol 2009, 46:1919-24.
72. Krause S, Reese G, Randow S, Zennaro D, Quaratino D, Palazzo P,
Ciardiello MA, Petersen A, Becker WM, Mari A: Lipid transfer pro-
tein (Ara h 9) as a new peanut allergen relevant for a Medi-
terranean allergic population.  J Allergy Clin Immunol 2009.
73. Kobayashi A, Tanaka H, Hamada Y, Ishizaki S, Nagashima Y, Shiomi K:
Comparison of allergenicity and allergens between fish white
and dark muscles.  Allergy 2006, 61:357-63.
74. Taylor SL: Molluscan shellfish allergy.  Adv Food Nutr Res 2008,
54:139-77.
75. Fernandes J, Reshef A, Patton L, Ayuso R, Reese G, Lehrer SB:
Immunoglobulin E antibody reactivity to the major shrimp
allergen, tropomyosin, in unexposed Orthodox Jews.  Clin Exp
Allergy 2003, 33:956-61.
76. Lemon-Mule H, Sampson HA, Sicherer SH, Shreffler WG, Noone S,
Nowak-Wegrzyn A: Immunologic changes in children with egg
allergy ingesting extensively heated egg.  J Allergy Clin Immunol
2008, 122:977-83.
77. Skamstrup Hansen K, Ballmer-Weber BK, Sastre J, Lidholm J, Anders-
son K, Oberhofer H, Lluch-Bernal M, Ostling J, Mattsson L, Schocker
F, Vieths S, Poulsen LK: Component-resolved in vitro diagnosis
of hazelnut allergy in Europe.  J Allergy Clin Immunol 2009,
123:1134-41.
78. Klinnert MD, Nelson HS, Price MR, Adinoff AD, Leung DY, Mrazek
DA: Onset and persistence of childhood asthma: predictors
from infancy.  Pediatrics 2001, 108:E69.
79. Kaila M, Rautava P, Holmberg-Marttila D, Vahlberg T, Aromaa M, Sil-
lanpaa M: Allergy from infancy to adolescence. A population-
based 18-year follow-up cohort.  BMC Pediatr 2009, 9:46.
80. Maas T, Kaper J, Sheikh A, Knottnerus JA, Wesseling G, Dompeling E,
Muris JW, van Schayck CP: Mono and multifaceted inhalant and/
or food allergen reduction interventions for preventing
asthma in children at high risk of developing asthma.
Cochrane Database Syst Rev 2009:CD006480.